Records containing: Systemic Lupus Erythematosus
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-02-25A First-in-Human, Randomized, Double-blind, Placebo-controlled, Sequential Parallel Group, Single Ascending Dose Study in Healthy Participants to Evaluate the Safety, Tolerability and Pharmacokinetics of KPG-818
-
CLINICAL_TRIALS study record update · 2020-02-24Nelfinavir in Systemic Lupus Erythematosus: A Pilot Phase IIa Clinical Trial
-
CLINICAL_TRIALS study record update · 2020-01-31An Open-label, Non-randomized, 52-Week Study to Evaluate Treatment Holidays and Rebound Phenomenon After Treatment With Belimumab 10 mg/kg in Systemic Lupus Erythematosus Subjects
-
CLINICAL_TRIALS study record update · 2020-01-27A Randomized, Double-Blind, Positive-Controlled, Placebo-Controlled, 4-Period Crossover Study to Investigate the Electrocardiographic Effects of BMS-986165 in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2020-01-27A Prospective, Double-blind, Randomized, Placebo-controlled, Repeated Dose, Multicentre Phase IIa Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-01-09BEL114333, a Multicenter, Continuation Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE) Who Completed the Phase III Study BEL113750 in Northeast Asia or Completed the Open-label Extension of HGS1006-C1115 in Japan
-
CLINICAL_TRIALS study record update · 2019-12-18A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study Characterizing the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab Following Subcutaneous Administration in Adult Systemic Lupus Erythematosus Subjects With Type I Interferon Test High Result and Active Skin Manifestations.
-
CLINICAL_TRIALS study record update · 2019-12-17Insulin Resistance and Atherosclerosis in a Sample of Women With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2019-12-12A Phase I, Open-Labeled, Dose-Ascending Clinical Trial of Immunotherapy of MRA, A Humanized Anti-IL 6 Receptor Monoclonal Antibody, In Patients With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2019-12-03Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)
-
CLINICAL_TRIALS study record update · 2019-11-29A Randomized, Double-Blind, Placebo-Controlled 52-Week Study to Assess Adverse Events of Special Interest in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab
-
CLINICAL_TRIALS study record update · 2019-10-23Duke Autoimmunity in Pregnancy Registry
-
CLINICAL_TRIALS study record update · 2019-10-10Transcutaneous Vagus Nerve Stimulation for the Treatment of Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2019-10-01Haematological Indices in Systemic Lupus Erythematosus and Their Association With Disease Activity
-
CLINICAL_TRIALS study record update · 2019-09-17A Multicenter, Randomised, Double-blind Placebo Controlled Trial on the Efficacy and Safety of add-on Metformin to Conventional Immunosuppressants in Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2019-09-04Immunogenicity and Safety of a Herpes Zoster Vaccine (Zostavax) in Patients With Systemic Lupus Erythematosus: a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2019-09-04Monitoring the IMmUological TOXicity of Drugs
-
CLINICAL_TRIALS study record update · 2019-08-21Utility of a Measure of Lupus Low Disease Activity State (LLDAS) in SLE: Pooled Analysis of the HGS1006-C1056 (BLISS-76) and HGS1006-C1057 (BLISS-52) Trials
-
CLINICAL_TRIALS study record update · 2019-08-09A Randomized, Double-Blinded, Placebo-Controlled Study of the Effect of XmAb®5871 on Systemic Lupus Erythematosus Disease Activity
-
CLINICAL_TRIALS study record update · 2019-08-01A Phase I Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Trial in Healthy Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ICP-022 Following Single and Multiple Escalating Dose
-
CLINICAL_TRIALS study record update · 2019-07-24Predictors of Mortality in Patients With Autoimmune Diseases Admitted to the Intensive Care Unit - Retrospective Analysis at a Single Tertiary Care Center
-
CLINICAL_TRIALS study record update · 2019-07-16Association of Heart Structure and Function Abnormalities With Laboratory Findings in Patients With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2019-07-05A Phase 3/4, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Adult Subjects of Black Race With Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2019-06-10Ramipril Improves Endothelial Function and Endothelial Progenitor Cells in Patients With Systemic Lupus Erythematosus: a Randomized and Controlled Study.
-
CLINICAL_TRIALS study record update · 2019-04-18B Cell Activating Factor Belonging to the TNF (Tumor Necrosis Factor) Family (BAFF) and a Proliferation-inducing Ligand (APRIL) in Patients With Systemic Lupus Erythematosus: Investigating Biomarkers for the Response to the Belimumab Treatment